echoloc
Get started
echoloc/ Companies/ Immunome, Inc.
Company profile

Immunome, Inc. Tech Stack

Clinical-stage oncology biotech developing ADCs and radioligand therapies

Biotechnology Research Bothell, Washington 201–500 employees Public Company
immunome.com LinkedIn

Immunome is a clinical-stage oncology developer whose stack is dominated by pharmacometrics and clinical data tools (NONMEM, Monolix, WinNonlin, SAS, Medidata Rave, Veeva CDMS, CDISC), pointing to heavy in-house PK/PD modeling and submission work. Senior- and director-heavy hiring across research, legal, quality and manufacturing, plus a Global Regulatory Lead opening, signals a company preparing for late-stage regulatory filings while scaling ADC process development.

Tech Stack 31 technologies

Core StackSAS MATLAB Greenhouse DocuSign NetSuite ServiceNow Intune Zoom WinNonlin NONMEM Monolix Shiny LC-MS/MS Veeva RIM GCP Microsoft Lists Microsoft Forms Ironclad Adobe Acrobat Medidata Rave Veeva CDMS LC-MS Cornerstone CDISC Exchange Online Jamf NinjaOne Veeva Vault Box Adobe+1 more

What Immunome, Inc. Is BuildingChallenges and projects from their job posts

◆Challenges

  • Complex, submission-ready regulatory filings and data packages
  • Delivering clinical trials on time and budget
  • Maintaining inspection readiness
  • Vendor performance and supplier delays
  • Data quality and CDISC compliance
  • Dose selection uncertainty

▲Active Projects

  • Late-stage development of varegacestat
  • Early-stage radiopharmaceutical program
  • ADC conjugation and multi-gram purification process development
  • Quality management system and audit program implementation
  • Validating CRO SDTM/ADaM datasets with SAS tooling
  • Oncology bioanalytical strategy

Hiring Activity

Accelerating40 roles · 20 in 30d

Department

Research
9
Healthcare
5
Legal
4
Manufacturing
3
Quality
3
Clinical
2
Data
2
Finance
2

Seniority

Senior
19
Director
11
Principal
5
Manager
2
Mid
2

Notable leadership hires: Global Regulatory Lead, Medical Director

Companies like Immunome, Inc.

200+ Biotechnology Research companies running SAS

See the full list

About Immunome, Inc.

Immunome, Inc. is a public, clinical-stage biotechnology company headquartered in Bothell, Washington, focused on targeted cancer therapies. Its pipeline spans a gamma secretase inhibitor in Phase 3 for desmoid tumors, a ROR1-targeted antibody-drug conjugate in Phase 1, a FAP-targeted radioligand cleared to enter clinical trials, and several preclinical ADCs aimed at solid tumors. The company employs between 201 and 500 people and hires in the United States. Operations run on Veeva Vault and Veeva RIM for regulatory content, NetSuite for finance, and ServiceNow, Intune and Jamf for IT.

HeadquartersBothell, Washington
Company Size201–500 employees
Hiring MarketsUnited States

Frequently Asked Questions

What software does Immunome use for clinical data and modeling?

Immunome uses SAS, NONMEM, Monolix, WinNonlin, MATLAB and Shiny for analysis and modeling, with Medidata Rave, Veeva CDMS and CDISC standards for clinical data management.

Is Immunome hiring?

Yes, hiring is accelerating in the United States, concentrated in research, healthcare, legal, manufacturing and quality, with open leadership roles including a Global Regulatory Lead and a Medical Director.

Where is Immunome headquartered?

Immunome is headquartered in Bothell, Washington, United States, and has between 201 and 500 employees.

Similar Companies in Biotechnology Research

Other companies in the same industry, closest in size

K
Kymera Therapeutics
Biotechnology Research
P
Praxis Precision Medicines, Inc.
Biotechnology Research
S
Structure Therapeutics
Biotechnology Research
G
Generate:Biomedicines
Biotechnology Research

How this profile is built

Immunome, Inc.'s technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →

This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.